Clinical Trial Update: Very Low Nicotine Cigarettes in Smokers With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating very low nicotine cigarettes in individuals with schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Dependence

Snippet

Sponsor: Brown University | Conditions: Tobacco Dependence | Phase 2 | Status: COMPLETED